- In January 2023, AmerisourceBergen Corporation completed its acquisition of PharmaLex Holding GmbH, a leading provider of regulatory and other services in the life sciences industry, which significantly expanded AmerisourceBergen’s service portfolio in a key market
- In August 2022, PharmaLex Group merged with Finland-based DRA Consulting, a consulting firm specializing in pharmacovigilance, market access, quality and manufacturing, regulatory services, and more, bringing comprehensive service solutions to PharmaLex’s offerings with over 300 clients
- In April 2022, VCLS entered into a partnership with EC Innovations, a global Chinese translation service provider experienced in translating highly regulated medical and life sciences content, which strengthened VCLS’s capabilities and broadened its service offerings
- In December 2021, Thermo Fisher Scientific Inc. completed its acquisition of PPD, Inc., a prominent service provider in the biotech and biopharma industries, integrating PPD into Thermo Fisher’s Laboratory Products and Services unit and broadening the company’s reach in clinical development, covering areas from scientific discovery to therapeutics production
- In December 2021, Labcorp finalized its acquisition of Toxikon Corporation, a contract research organization specializing in nonclinical testing services, enhancing Labcorp’s nonclinical development portfolio and solidifying its position as a strategic partner for pharmaceutical and biotechnology clients
Frequently Asked Questions
The market is segmented based on Segmentation, By Services (Regulatory Writing and Publishing, Regulatory Submissions, Clinical Trial Applications and Services Registrations, Regulatory Consulting and Legal Representation, and Other Regulatory Affairs), End-User (Mid-Size Pharmaceutical Companies, Large Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, and Food and Beverage Companies) – Industry Trends and Forecast to 2032
.
The Global Healthcare Regulatory Affairs Outsourcing Market size was valued at USD 6.42 USD Billion in 2024.
The Global Healthcare Regulatory Affairs Outsourcing Market is projected to grow at a CAGR of 10.71% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
